Improving recovery after breast reconstruction using autologous tissue
Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)
This study is testing new ways to help women recover better after breast reconstruction surgery using their own tissue, focusing on reducing complications and improving satisfaction.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 380 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | Female |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT05363189 on ClinicalTrials.gov |
What this trial studies
This study investigates how to optimize postoperative recovery for women undergoing breast reconstruction with autologous tissue, specifically the DIEP flap technique. It aims to modify pre-, peri-, and postoperative protocols to reduce healthcare resource usage while ensuring low complication rates and high patient satisfaction. The study will evaluate various interventions, including venous augmentation and enhanced recovery after surgery (ERAS) protocols, to determine their effectiveness in improving recovery outcomes.
Who should consider this trial
Good fit: Ideal candidates are women over 18 years old who are undergoing or have undergone breast reconstruction with a DIEP flap.
Not a fit: Patients who cannot provide informed consent or do not speak Swedish may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more efficient recovery protocols that enhance patient satisfaction and reduce healthcare costs for breast reconstruction surgeries.
How similar studies have performed: While there have been studies on enhancing recovery after surgery, this specific approach focusing on autologous tissue breast reconstruction is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Operated or will be operated with a DIEP flap in the department * \>18 years of age Exclusion Criteria: * Inability to leave informed consent * Inability to understand and speak Swedish (for the questionnaire)
Where this trial is running
Gothenburg
- Sahlgrenska university hospital — Gothenburg, Sweden (Recruiting)
Study contacts
- Study coordinator: Emma Hansson, MD, PhD
- Email: emma.em.hansson@vgregion.se
- Phone: 0046313421000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.